Vincere Biosciences
United States · $5.0M raised
- Employees
- 1–10
- Business Model
- B2B
- Website
- vincere.bio
- Total Funding
- $5.0M
- Last Round
- $5.0M SeedNov 2025
- Rounds
- 2
About
Biotech developing small molecules targeting mitophagy to treat age-related diseases like Parkinson's and kidney disease.
Summary
Vincere Biosciences is a Biotech company based in United States. It has raised $5.0M in total across 2 rounds, most recently a $5.0M Seed round in Nov 2025. Investors include Draper Associates, Alumni Ventures and LongGame.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.